{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:08:25Z","timestamp":1765814905872,"version":"3.48.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,12]]},"abstract":"<jats:p>\n                    Acute myeloid leukemia (AML) remains a challenging hematologic malignancy with poor survival rates, underscoring the need for precise prognostic biomarkers and therapeutic strategies. Cancer-testis antigens (CTAs), with tumor-restricted expression and immunogenicity, have not been systematically explored for prognosis prediction in AML. Here, we developed a novel CTA-based prognostic signature to predict survival and immunotherapy response in AML patients. Utilizing RNA-seq and clinical data from the TCGA-Acute Myeloid Leukemia cohort (n\u2005=\u2005126, training set) and the GSE71014 dataset (n\u2005=\u2005104, validation set), we identified 21 prognosis-associated CTAs via univariate Cox regression. Least absolute shrinkage and selection operator and multivariate Cox regression refined the model to 5 key genes: ACRBP, IGF2BP3, SPAG1, TEX101, and KDM5B. The CTA score, calculated from gene expression and regression coefficients, stratified patients into high- and low-risk groups with distinct overall survival (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). The model exhibited robust predictive accuracy, with time-dependent area under the curve values of 0.863 (TCGA-Acute Myeloid Leukemia training set) and 0.723 (GSE71014 validation cohort) for 5-year overall survival. High CTA scores correlated with adverse prognosis, elevated monocytes and M0 macrophages infiltration, and enhanced immunotherapy responsiveness. Functional enrichment analysis revealed dysregulation in several key AML-related pathways, including leukocyte migration, PI3K-Akt signaling, and cytokine pathways. A nomogram integrating CTA score and age further improved prognostic precision (concordance index\u2005=\u20050.77). Drug sensitivity profiling highlighted differential therapeutic vulnerabilities between risk groups. This study established and validated a novel CTA-based prognostic tool for prognostic stratification and personalized treatment guidance in AML, bridging molecular insights with clinical applications.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046374","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:03:44Z","timestamp":1765814624000},"page":"e46374","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A cancer-testis antigen signature for predicting prognosis and response to immunotherapy in acute myeloid leukemia"],"prefix":"10.1097","volume":"104","author":[{"given":"Mihribangvl","family":"Alip","sequence":"first","affiliation":[{"name":"Department of General Surgery, Kashi Prefecture Second People\u2019s Hospital, Kashi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilimureti","family":"Ainiwaer","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Kashi Prefecture Second People\u2019s Hospital, Kashi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanwen","family":"Chang","sequence":"additional","affiliation":[{"name":"Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University, Shanghai, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifeng","family":"Yuan","sequence":"additional","affiliation":[{"name":"Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University, Shanghai, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abudukadier","family":"Aimaieryili","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Kashi Prefecture Second People\u2019s Hospital, Kashi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Kashi Prefecture Second People\u2019s Hospital, Kashi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Kashi Prefecture Second People\u2019s Hospital, Kashi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mairanmunisha","family":"Tuerxun","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Kashi Prefecture Second People\u2019s Hospital, Kashi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaermaimaiti","family":"Musa","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Kashi Prefecture Second People\u2019s Hospital, Kashi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuermaimati","family":"Yusuying","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Kashi Prefecture Second People\u2019s Hospital, Kashi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurnisagul","family":"Mamatkerim","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Kashi Prefecture Second People\u2019s Hospital, Kashi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1368-6278","authenticated-orcid":false,"given":"Abudukadir","family":"Tursun","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Kashi Prefecture Second People\u2019s Hospital, Kashi, Xinjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia.","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia.","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajh.24246","article-title":"Acute myeloid leukemia \u2013 major progress over four decades and glimpses into the future.","volume":"91","author":"Kantarjian","year":"2016","journal-title":"Am J Hematol"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms.","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"R7-20251215","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data.","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia.","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2022.280801","article-title":"The clinical impact of the molecular landscape of acute myeloid leukemia.","volume":"108","author":"Kayser","year":"2023","journal-title":"Haematologica"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40364-020-00208-1","article-title":"AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.","volume":"8","author":"Pogosova-Agadjanyan","year":"2020","journal-title":"Biomark Res"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer.","volume":"5","author":"Simpson","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/08820139.2016.1197241","article-title":"Cancer\/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers.","volume":"45","author":"Salmaninejad","year":"2016","journal-title":"Immunol Invest"},{"key":"R13-20251215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions.","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"R14-20251215","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-pharmtox-011112-140326","article-title":"Cause and consequence of cancer\/testis antigen activation in cancer.","volume":"54","author":"Whitehurst","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R15-20251215","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tranon.2019.02.008","article-title":"Cancer-testis antigen peptide vaccine for cancer immunotherapy: progress and prospects.","volume":"12","author":"Wei","year":"2019","journal-title":"Transl Oncol"},{"key":"R16-20251215","doi-asserted-by":"crossref","first-page":"107889","DOI":"10.1016\/j.intimp.2021.107889","article-title":"A novel era of cancer\/testis antigen in cancer immunotherapy.","volume":"98","author":"Meng","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"188558","DOI":"10.1016\/j.bbcan.2021.188558","article-title":"Oncogenic cancer\/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.","volume":"1876","author":"Yang","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R18-20251215","doi-asserted-by":"crossref","first-page":"D816","DOI":"10.1093\/nar\/gkn673","article-title":"CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens.","volume":"37","author":"Almeida","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"39098","DOI":"10.18632\/oncotarget.5390","article-title":"An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype.","volume":"6","author":"Chuang","year":"2015","journal-title":"Oncotarget"},{"key":"R20-20251215","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles.","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"R21-20251215","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry.","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"key":"R22-20251215","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data.","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"R23-20251215","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"R24-20251215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-scale public data reuse to model immunotherapy response and resistance.","volume":"12","author":"Fu","year":"2020","journal-title":"Genome Med"},{"key":"R25-20251215","doi-asserted-by":"crossref","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data.","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief Bioinform"},{"key":"R26-20251215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions.","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J"},{"key":"R27-20251215","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth.","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"R28-20251215","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","article-title":"Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.","volume":"27","author":"Pitt","year":"2016","journal-title":"Ann Oncol"},{"key":"R29-20251215","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1158\/0008-5472.CAN-10-0840","article-title":"Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation.","volume":"70","author":"Whitehurst","year":"2010","journal-title":"Cancer Res"},{"key":"R30-20251215","doi-asserted-by":"crossref","first-page":"E3696","DOI":"10.1073\/pnas.1522333113","article-title":"Biogenesis of sperm acrosome is regulated by pre-mRNA alternative splicing of Acrbp in the mouse.","volume":"113","author":"Kanemori","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-20251215","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/cbin.11567","article-title":"CT23 knockdown attenuating malignant behaviors of hepatocellular carcinoma cell is associated with upregulation of metallothionein 1.","volume":"45","author":"Ning","year":"2021","journal-title":"Cell Biol Int"},{"key":"R32-20251215","first-page":"7591","article-title":"Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma.","volume":"13","author":"Ge","year":"2021","journal-title":"Am J Transl Res"},{"key":"R33-20251215","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/iid3.534","article-title":"Cancer-testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: its association with prognosis.","volume":"9","author":"Lin","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"R34-20251215","doi-asserted-by":"crossref","first-page":"jcs259512","DOI":"10.1242\/jcs.259512","article-title":"The role of SPAG1 in the assembly of axonemal dyneins in human airway epithelia.","volume":"135","author":"Smith","year":"2022","journal-title":"J Cell Sci"},{"key":"R35-20251215","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/molehr\/7.9.811","article-title":"Expression and function of the HSD-3.8 gene encoding a testis-specific protein.","volume":"7","author":"Lin","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"R36-20251215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12920-022-01193-0","article-title":"Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation.","volume":"15","author":"Gu","year":"2022","journal-title":"BMC Med Genomics"},{"key":"R37-20251215","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4149\/neo_2022_220415N416","article-title":"SPAG1 promotes the development of AML by activating the ERK\/MAPK signaling pathway and affects the chemotherapy sensitivity of venetoclax.","volume":"69","author":"Liu","year":"2022","journal-title":"Neoplasma"},{"key":"R38-20251215","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.onc.1209961","article-title":"Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells.","volume":"26","author":"Neesse","year":"2007","journal-title":"Oncogene"},{"key":"R39-20251215","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2147\/OTT.S288484","article-title":"Expression and prognosis of sperm-associated antigen 1 in human breast cancer.","volume":"14","author":"Lin","year":"2021","journal-title":"Onco Targets Ther"},{"key":"R40-20251215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation.","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"key":"R41-20251215","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","article-title":"The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.","volume":"54","author":"Zhang","year":"2022","journal-title":"Exp Mol Med"},{"key":"R42-20251215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-024-02013-y","article-title":"N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.","volume":"23","author":"Wen","year":"2024","journal-title":"Mol Cancer"},{"key":"R43-20251215","doi-asserted-by":"crossref","first-page":"e1628","DOI":"10.1002\/ctm2.1628","article-title":"m6A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia.","volume":"14","author":"Zhao","year":"2024","journal-title":"Clin Transl Med"},{"key":"R44-20251215","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s00018-009-8482-2","article-title":"A sperm GPI-anchored protein elicits sperm-cumulus cross-talk leading to the acrosome reaction.","volume":"66","author":"Yin","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"R45-20251215","doi-asserted-by":"crossref","first-page":"M110.004127","DOI":"10.1074\/mcp.M110.004127","article-title":"Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay.","volume":"10","author":"Drabovich","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"R46-20251215","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1111\/j.1582-4934.2008.00576.x","article-title":"A suppressor of multiple extracellular matrix-degrading proteases and cancer metastasis.","volume":"13","author":"Yin","year":"2009","journal-title":"J Cell Mol Med"},{"key":"R47-20251215","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2007.02.017","article-title":"The X-linked mental retardation gene SMCX\/JARID1C defines a family of histone H3 lysine 4 demethylases.","volume":"128","author":"Iwase","year":"2007","journal-title":"Cell"},{"key":"R48-20251215","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.cell.2007.02.003","article-title":"RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3.","volume":"128","author":"Christensen","year":"2007","journal-title":"Cell"},{"key":"R49-20251215","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2007.03.001","article-title":"PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation.","volume":"25","author":"Yamane","year":"2007","journal-title":"Mol Cell"},{"key":"R50-20251215","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccell.2015.06.003","article-title":"The H3K4-methyl epigenome regulates leukemia stem cell oncogenic potential.","volume":"28","author":"Wong","year":"2015","journal-title":"Cancer Cell"},{"key":"R51-20251215","doi-asserted-by":"crossref","first-page":"e2122940119","DOI":"10.1073\/pnas.2122940119","article-title":"A PRC2-KDM5B axis sustains tumorigenicity of acute myeloid leukemia.","volume":"119","author":"Ren","year":"2022","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:03:50Z","timestamp":1765814630000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":51,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046374","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"2025-03-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}